These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15089052)

  • 41. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the artificial membrane permeability of drugs by digital simulation.
    Nakamura M; Osakai T
    Eur J Pharm Sci; 2016 Aug; 91():154-61. PubMed ID: 27334569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.
    Charkoftaki G; Dokoumetzidis A; Valsami G; Macheras P
    Pharm Res; 2012 Nov; 29(11):3188-98. PubMed ID: 22760660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique.
    Bujard A; Sol M; Carrupt PA; Martel S
    Eur J Pharm Sci; 2014 Oct; 63():36-44. PubMed ID: 25008117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug permeability profiling using cell-free permeation tools: Overview and applications.
    Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of drug metabolism for prediction of intestinal permeability (dagger).
    Chen ML; Yu L
    Mol Pharm; 2009; 6(1):74-81. PubMed ID: 19132929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative analysis for lipophilic drug transport through a model lipid membrane with membrane retention.
    Lee Y; Choi SQ
    Eur J Pharm Sci; 2019 Jun; 134():176-184. PubMed ID: 31022441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High throughput artificial membrane permeability assay for blood-brain barrier.
    Di L; Kerns EH; Fan K; McConnell OJ; Carter GT
    Eur J Med Chem; 2003 Mar; 38(3):223-32. PubMed ID: 12667689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
    Wu CY; Benet LZ
    Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability.
    Dargó G; Vincze A; Müller J; Kiss HJ; Nagy ZZ; Balogh GT
    Eur J Pharm Sci; 2019 Feb; 128():232-239. PubMed ID: 30553815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies.
    Mishra V; Gupta U; Jain NK
    Pharmazie; 2010 Mar; 65(3):155-61. PubMed ID: 20383933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.
    Papich MG; Martinez MN
    AAPS J; 2015 Jul; 17(4):948-64. PubMed ID: 25916691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
    Oja M; Maran U
    Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
    Batchelor HK; Kendall R; Desset-Brethes S; Alex R; Ernest TB;
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):833-42. PubMed ID: 23665448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs.
    de Souza Teixeira L; Vila Chagas T; Alonso A; Gonzalez-Alvarez I; Bermejo M; Polli J; Rezende KR
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33086670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simulation-based comparison of Biopharmaceutics Classification System and drug structure.
    Chen T; Wu T; Li N; Jiang Y; Yin H; Wu M
    Pharmazie; 2020 Apr; 75(4):124-130. PubMed ID: 32295687
    [No Abstract]   [Full Text] [Related]  

  • 59. The utility of rat jejunal permeability for biopharmaceutics classification system.
    Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
    Wohnsland F; Faller B
    J Med Chem; 2001 Mar; 44(6):923-30. PubMed ID: 11300874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.